biolegend流式抗体-APC anti-mouse CD45.2 Antibody

Pricing & Availability

Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
APC anti-mouse CD45.2 Antibody
C57BL/6 mouse splenocytes stained with 104 APC
  • APC anti-mouse CD45.2 Antibody
    C57BL/6 mouse splenocytes stained with 104 APC

Compare all formats See APC spectral data

Input string was not in a correct format.
Input string was not in a correct format.
Cat # Size Price Quantity Check Availability Save
109813 25 µg $30.00

Check Availability

Need larger quantities of this item?
Request Bulk Quote

109814 100 µg $105.00

Check Availability

Need larger quantities of this item?
Request Bulk Quote

Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details

Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC – Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis6 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3

Application References

(PubMed link indicates BioLegend citation)

  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  2. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  3. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  4. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  5. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  6. Xu X, et al. 2018. Cell. 175:1336. PubMed
  7. Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
  8. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  9. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  10. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  11. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  12. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  13. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  14. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  15. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  16. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  17. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  18. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  19. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  20. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  21. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  22. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  23. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  24. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  25. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  26. Woodworth JS, et al. 2017. Mucosal Immunol. 0.802083333. PubMed
  27. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  28. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  29. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  30. Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed
  31. Han CY, et al. 2020. Cell Reports. 31(13):107818. PubMed
  32. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  33. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  34. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  35. Takizawa H, et al. 2011. J Exp Med. 208:273. PubMed
  36. Markey K, et al. 2012. Blood. 119:5918. PubMed
  37. Santamaria-Martínez A, et al. 2009. Exp Cell Res. 315:3004. PubMed
  38. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  39. Brocq M, et al. 2014. J Immunol. 192:6120. PubMed
  40. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  41. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  42. Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
  43. Koyama M, et al. 2015. J Exp Med. 212: 1303 – 1321. PubMed
  44. Gordon E, et al. 2015. Proc Natl Acad Sci U S A. 112: 13075 – 13080. PubMed
  45. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  46. Kondo M, et al. 2016. J Immunol. 196: 563 – 572. PubMed
  47. Jutz S, et al. 2016. J Immunol Methods. 430:10-20. PubMed
  48. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  49. Kalinski AL, et al. 2020. Elife. 9:00. PubMed
  50. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  51. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  52. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  53. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  54. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  55. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  56. Dufva O, et al. 2020. Cancer Cell. 38(3):380-399.e13. PubMed
  57. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  58. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  59. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  60. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  61. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  62. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  63. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  64. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  65. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  66. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  67. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  68. Lu SX, et al. 2021. Cell. . PubMed
  69. Marangoni F, et al. 2021. Cell. . PubMed
RRID
AB_389210 (BioLegend Cat. No. 109813)
AB_389211 (BioLegend Cat. No. 109814)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Related Products

Description Clone Applications

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45.2 Reagents Request Custom Conjugation

Description Clone Applications
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC, Block, IHC-F, IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC

发表评论